^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IGV-001

    i
    Associations
    News

    Trials

    Company:
    Imvax
    Drug class:
    IGF-1R inhibitor, Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma (NCT04485949)
    Phase 2
    Imvax
    Active, not recruiting
    Last update posted :
    05/31/2024
    Initiation :
    03/20/2023
    Primary completion :
    01/01/2025
    Completion :
    07/01/2027
    MGMT
    |
    temozolomide • IGV-001